2935 Conroy Road Ottawa Ontario, Canada K1G 6C6

# 510(k) SUMMARY

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) number is:

# Summary Prepared:

June 7, 2006

Submitted by:

Epocal Inc.   
2935 Conroy Road, Ottawa, Ontario, Canada K1G 6C6 Telephone: (613) 738-6192   
Fax: (613) 738-6195

# Contact:

Roy Layer Director of Quality Assurance and Regulatory Affairs.

# 5.1 Identification of the Device

Device Name:   
Proprietary / Trade Name:   
Common Name:   
Classification Name:   
Device Classification:   
Regulation Number:   
Panel:   
Product Code:   
EPOC™ Blood Analysis System   
EPOC Blood Analysis System   
Portable Blood Analyzer   
See Tables Below   
See Tables Below   
See Tables Below   
See Tables Below   
See Tables Below

Figure 5.1 - Table - EPOC™M Blood Analysis System with Blood Gas Electrolyte (BGE) Test Card   

<table><tr><td rowspan=1 colspan=1>Name</td><td rowspan=1 colspan=1>Class</td><td rowspan=1 colspan=1>RegulationNumber</td><td rowspan=1 colspan=1>Panel</td><td rowspan=1 colspan=1>ProductCode</td></tr><tr><td rowspan=1 colspan=1>Electrode, Ion Specific, Sodium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1665</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>JGS</td></tr><tr><td rowspan=1 colspan=1>Electrode, Ion Specific, Potassium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1600</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>CEM</td></tr><tr><td rowspan=1 colspan=1>Hematocrit</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>864.6400</td><td rowspan=1 colspan=1>Hematology</td><td rowspan=1 colspan=1>JPI</td></tr><tr><td rowspan=1 colspan=1>Electrode, Ion Specific, Calcium</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1145</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>JFP</td></tr><tr><td rowspan=1 colspan=1>Electrode Measurement, Blood-Gases (PCO2, PO2) and Blood pH</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1120</td><td rowspan=1 colspan=1>ClinicalChemistry</td><td rowspan=1 colspan=1>CHL</td></tr></table>

# 5.2 Identification of the Predicate Device

i-Stat™ Model 300 Portable Clinical Analyzer

# 5.3 Description of the New Device

The EPOC system is a new device that has never been marketed in the United States of America. There are no previous related 510k submissions for this device.

The EPOC Blood Analysis System consists of three (3) components:

. EPOC Test Card

The single use blood test card comprises a port for introduction of a blood sample to an array of sensors on a sensor module. The sensor module is mounted proximal to a fluidic channel contained in a credit-card sized housing. The card has an on-board calibrator contained in a sealed reservoir fluidically connected to the senor array through a valve.

2EPOC Card Reader

The reader is a minimally featured raw-signal acquisition peripheral. The reader comprises a card orifice for accepting a test card, and a mechanical actuation assembly for engaging the test card after it is inserted into the card orifice. Within the reader's card orifice there is a bar code scanner, an electrical contact array for contacting the card's sensor module, and a thermal subsystem for heating the card's measurement region to $3 7 ^ { \circ } \mathsf { C }$ during the test. The reader also comprises circuits for amplifying, digitizing and converting the raw sensor signals to a wireless transmittable Bluetooth™ format,

# 3. EPOC Host

The host is a dedicated use Personal Digital Assistant (PDA) computing device with custom software that displays the test results. The reader and host computer together constitute all of the subsystems generally found in a traditional analyzer that operates on unit-use sensors and reagents

# 5.4 Intended Use of the Device

The EPOC Blood Analysis System is intended for use by trained medical professionals as an in vitro diagnostic device for the quantitative testing of samples of whole blood in the laboratory or at the point of care in hospitals, nursing homes or other clinical care institutions.

The BGE test card panel configuration includes sensors for Sodium Na, Potassium K, Ionized Calcium iCa, pH, $p \mathsf { C O } _ { 2 } , p \mathsf { O } _ { 2 }$ and Hematocrit Hct.

Measurement of sodium and potassium are used in diagnosis and treatment of diseases involving electrolyte imbalance. Measurement of ionized calcium is used in diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany. Measurement of pH, pCO2 and pO2 (blood gases) is used in the diagnosis and treatment of life-threatening acid-base disturbances. Measurement of hematocrit distinguishes normal from abnormal states of blood red cell volume, such as in anemia and erythrocytosis

# 5.5 Comparison of Technological Characteristics To Predicate Device

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>EPOC Blood Analysis System</td><td rowspan=1 colspan=1>i-STAT Model 300</td><td rowspan=3 colspan=1>Same /Different</td></tr><tr><td rowspan=1 colspan=1>510(k) #</td><td rowspan=1 colspan=1>To be determined</td><td rowspan=1 colspan=1>K001387</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Intendeduse</td><td rowspan=1 colspan=1>The EPOC Blood Analysis System isintended for use by trained medicalprofessionals as an in vitro diagnosticdevice for the quantitative testing ofsamples of whole blood using the BGE(Blood Gas Electrolyte) and ABG(Arterial Blood Gas) test card panels.</td><td rowspan=1 colspan=1>The i-STAT Model 300 Portable ClinicalAnalyzer is intended to be used bytrained medical professionals for usewith i-STAT test cartridges andMediSense blood glucose test strips.i-STAT cartridges comprise a varietyof clinical chemistry tests and testpanels.</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Where used</td><td rowspan=1 colspan=1>hospital</td><td rowspan=1 colspan=1>hospital</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Measuredparameters</td><td rowspan=1 colspan=1>pH, pCOz, pO2, Na, K, iCa, Hct</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na, K, iCa, Hct</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Calculatedparameters</td><td rowspan=1 colspan=1>TCO2, HCO3,BE,SO2,Hgb</td><td rowspan=1 colspan=1>TCO2, HCO3,BE,sO2,Hgb</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Sample type</td><td rowspan=1 colspan=1>Venous, arterial whole blood</td><td rowspan=1 colspan=1>Venous, arterial and skin puncturewhole blood</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Reportableranges</td><td rowspan=1 colspan=1>pH     6.5-8.0        pH unitspCO  5 - 250         mm HgpO2    5 - 750         mm HgNa     85 - 180        mmol/LK       1.5 - 12         mmol/LiCa     0.25 - 4        mmol/LHct    10 - 75          %PCVTCO2  1-85           mmol/LHCO3  1- 85           mmol/LBEecf   -30 - +30       mmol/LBEb     -30 - +30       mmol/LsO2    0 - 100         %Hb     3.3 -25         g/dL</td><td rowspan=1 colspan=1>pH     6.5- 8.2       pH unitspCO2  5 - 130         mm HgpO2    5-800         mm HgNa     100 - 180       mmol/LK      2.0 - 9.0        mmol/LiCa     0.25 - 2.5       mmol/LHct    10 - 75         %PCVTCO2  5 - 50           mmol/LHCO3  1-85           mmol/LBEecf   -30 - +30       mmol/LBEb    -30 - +30       mmol/LsO2    0 - 100          %Hb     3-26           g/dL</td><td rowspan=1 colspan=1>differentdififerentsamedifferentdifferentdifferentsamedifferentsamesamesamesamesame</td></tr><tr><td rowspan=1 colspan=1>Samplevolume</td><td rowspan=1 colspan=1>95-125 μL</td><td rowspan=1 colspan=1>100μL</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Test card</td><td rowspan=1 colspan=1>Unit-use card withon-board calibrator in sealedreservoiran electrochemical multi-sensorarrayport for sample introductionfluid waste chamber</td><td rowspan=1 colspan=1>Unit-use cartridge withon-board calibrator in sealedreservoiran electrochemical multi-sensorarrayport for sample introductionfluid waste chamber</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Test cardstorage</td><td rowspan=1 colspan=1>Room temperature until expiry date</td><td rowspan=1 colspan=1>Fridge storage until expiry dateincluding max 2 weeks at roomtemperature</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Sensor array</td><td rowspan=1 colspan=1>A laminated foil sensor module</td><td rowspan=1 colspan=1>A micro-fabricated chip-set</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Tests/sensorcomponents</td><td rowspan=1 colspan=1>pH - PVC ion selective electrodepCO2 - QH modified Severinghaustypep02 - membrane coated gold cathodeNa - PVC ion selective electrodeK - pVC ion selective electrodeiCa - PVC ion selective electrodeHct - conductivity, gold electrodes</td><td rowspan=1 colspan=1>pH - PVC ion selective electrodepCO2 - QH modified Severinghaustypep02 - membrane coated gold cathodeNa - PVC ion selective electrodeK - PVC ion selective electrodeiCa - PVC ion selective electrodeHct - conductivity, gold electrodes</td><td rowspan=1 colspan=1>samesamesamesamesamesamesame</td></tr><tr><td rowspan=1 colspan=1>Analyzercomponents</td><td rowspan=1 colspan=1>Two housings;1 - The reader comprisingOrifice for test card introductionelectrical connector to cardheater for 37°C operationmechanical card engagementdevice for</td><td rowspan=1 colspan=1>A single housing comprisingOrifice for test card introductionelectrical connector to cardheater for 37°C operationmechanical card engagementdevice for</td><td rowspan=1 colspan=1>differentsamesamesame</td></tr></table>

Figure 5.2 - Table Comparing EPOC Device Performance Characteristics With Predicate Device   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0 making electrical contactto card&#x27;s sensors0 for rupture of calibratorreservoirO moving calibrator tosensors0engaging heaters withcardop-amp sensor signal detectorsiQC monitoring devicesThermal controllersMUXA/DBluetooth stack for wirelesstransmission of digitized rawsensor signals to computingdevicebar code scanner for acquiringcard infointernal electronic reader self-testcircuit2 - The computing device comprisinga PDAmicroprocessormemorycolor LCD displaykeyboardi/o for communicating test resultsto other devicessoftware to control the test andcalculate analytical values fromraw sensor signalsbattery operated withrechargeable batteries via plug inplug-in power supply</td><td rowspan=1 colspan=1>0 making electrical contactto card&#x27;s sensors0 for rupture of calibratorreservoir• moving calibrator tosensorsengaging heaters with cardop-amp sensor signal detectorsiQC monitoring devicesThermal controllersMUXA/Dwire transmission of digitized rawsensor signals to computingsubsystem in same housingn/ainternal and external electronicreader self-test circuitmicroprocessormemorymonochrome LCD displaykeyboardi/o for communicating test resultsto other devicessoftware to control the test andcalculate analytical values fromraw sensor signalsbattery operated withrechargeable batteries viaexternal power supply indownloader cradle</td><td rowspan=1 colspan=1>samesamesamesamesamesamesamesamesamedifferentdifferentdifferentsamesamedifferentsamesamesamesame1</td></tr><tr><td rowspan=1 colspan=1>Measurementtemperature</td><td rowspan=1 colspan=1>37°C</td><td rowspan=1 colspan=1>37°C</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Measurementsequence</td><td rowspan=1 colspan=1>Calibrate test card-introduce sample-measure</td><td rowspan=1 colspan=1>Introduce sample-calibrate testcartridge-measure</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Measurementtime</td><td rowspan=1 colspan=1>30sec from sample introduction</td><td rowspan=1 colspan=1>200 sec from sample introduction</td><td rowspan=1 colspan=1>different</td></tr><tr><td rowspan=1 colspan=1>Errordetection</td><td rowspan=1 colspan=1>iQC system to detect user errorsiQC system for reader self-checkiQC system to detect card non-conformance</td><td rowspan=1 colspan=1>iQC system to detect user errorsiQC system for reader self-checkiQC system to detect card non-conformance</td><td rowspan=1 colspan=1>samesamesame</td></tr></table>

The EPoc System has the same intended use and utilizes the same test methodologies as the predicate device. Most of the system components are very similar to the predicate device. Differences between the EPoC device and the predicate device have no significant effect on the safety or effectiveness of the system.

# 5.6 Summary of Non-Clinical Test Performance in Support of Substantial Equivalence

# 5.6.1 Precision

Experiments were performed in-house to demonstrate the precision of the EPOC test methods. The table below shows the results of a twenty day precision study using aqueous controls at two levels L1 and L3 for the blood gases and electrolytes, and two levels of aqueous controls for Hematocrit, level A, level B.

<table><tr><td></td><td colspan="7">L1</td></tr><tr><td></td><td>pH</td><td>pCO2</td><td>pO2</td><td>Na</td><td>K</td><td>iCa</td><td>Hct</td></tr><tr><td>Mean</td><td>6.986</td><td>80.6</td><td>78.4</td><td>114.5</td><td>2.15</td><td>2.2</td><td>-16.9</td></tr><tr><td>SWR</td><td>0.006</td><td>1.94</td><td>1.94</td><td>0.57</td><td>0.021</td><td>0.023</td><td>0.35</td></tr><tr><td>%CVWR</td><td>0.09%</td><td>2.40%</td><td>2.47%</td><td>0.50%</td><td>0.97%</td><td>1.02%</td><td></td></tr><tr><td>SDD</td><td>0.004</td><td>1.31</td><td>1.96</td><td>0.67</td><td>0.011</td><td>0.017</td><td>0.42</td></tr><tr><td>%CVDD</td><td>0.05%</td><td>1.63%</td><td>2.50%</td><td>0.59%</td><td>0.51%</td><td>0.76%</td><td></td></tr><tr><td>ST</td><td>0.008</td><td>2.36</td><td>2.57</td><td>0.80</td><td>0.025</td><td>0.028</td><td>0.49</td></tr><tr><td>%CVT</td><td>0.11%</td><td>2.92%</td><td>3.28%</td><td>0.70%</td><td>1.15%</td><td>1.26%</td><td></td></tr></table>

<table><tr><td></td><td colspan="7">L3</td></tr><tr><td></td><td>pH</td><td>pCO2</td><td>pO2</td><td>Na</td><td>K</td><td>iCa</td><td>Hct</td></tr><tr><td>Mean</td><td>7.676</td><td>22.5</td><td>141.2</td><td>153.2</td><td>6.58</td><td>0.67</td><td>-14.5</td></tr><tr><td>SwR</td><td>0.005</td><td>0.36</td><td>1.78</td><td>0.71</td><td>0.053</td><td>0.009</td><td>0.36</td></tr><tr><td>%CVwR</td><td>0.06%</td><td>1.61%</td><td>1.26%</td><td>0.47%</td><td>0.80%</td><td>1.29%</td><td></td></tr><tr><td>SDD</td><td>0.004</td><td>0.55</td><td>1.44</td><td>0.77</td><td>0.037</td><td>0.010</td><td>0.33</td></tr><tr><td>%CVDD</td><td>0.05%</td><td>2.44%</td><td>1.02%</td><td>0.50%</td><td>0.56%</td><td>1.43%</td><td></td></tr><tr><td>ST</td><td>0.006</td><td>0.56</td><td>2.24</td><td>0.97</td><td>0.064</td><td>0.012</td><td>0.46</td></tr><tr><td>%CVT</td><td>0.08%</td><td>2.50%</td><td>1.58%</td><td>0.63%</td><td>0.98%</td><td>1.77%</td><td></td></tr></table>

Figure 5.3A - Table - 20 Day Precision Study Data   

<table><tr><td></td><td>Level A</td><td>Level B</td></tr><tr><td></td><td>Hct</td><td>Hct</td></tr><tr><td>Mean</td><td>25.3</td><td>46.1</td></tr><tr><td>SWR</td><td>0.370</td><td>0.68</td></tr><tr><td>%CVT</td><td>1.46%</td><td>1.48%</td></tr><tr><td>SDD</td><td>0.160</td><td>0.00</td></tr><tr><td>%CVT</td><td>0.63%</td><td>0.00%</td></tr><tr><td>S1</td><td>0.400</td><td>0.68</td></tr><tr><td>%CVT</td><td>1.58%</td><td>1.48%</td></tr></table>

Experiments were performed at three point of care sites with 7 point of care operators performing $\mathsf { n } { = } 1 0$ replicates on whole blood

In field trials, 10 replicates of different whole blood patient samples were run by different operators of the EPoC system at different point-of-care sites. Each precision study employed 5 different EPOC readers.

<table><tr><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>% CV</td></tr><tr><td rowspan=7 colspan=1>Site 1operator 1operator 2Site 2operator 3operator 4operator 5Site 3operator 6operator 7</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=3 colspan=1>143142143</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.0</td></tr><tr><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.6</td></tr><tr><td rowspan=3 colspan=1>143141140</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.5</td></tr><tr><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.7</td></tr></table>

<table><tr><td>K</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1 operator 2</td><td>4.0 4.0</td><td>0.05 0.00</td><td>1.3 0.0</td></tr><tr><td>Site 2 operator 3 operator 4</td><td>3.7 3.8</td><td>0.00 0.03</td><td>0.0</td></tr><tr><td>operator 5 Site 3 operator 6 operator 7</td><td>3.7 3.6</td><td>0.03 0.03</td><td>0.8 0.9 0.9</td></tr></table>

<table><tr><td>iCa</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1 operator 2</td><td>1.20 1.21</td><td>0.02</td><td>1.5</td></tr><tr><td rowspan="4">Site 2 operator 3 operator 4</td><td></td><td>0.02</td><td>1.9</td></tr><tr><td>1.19</td><td>0.02</td><td>1.7</td></tr><tr><td>1.21 operator 5</td><td>0.03</td><td>2.1</td></tr><tr><td>1.20</td><td>0.02</td><td>1.6</td></tr><tr><td rowspan="2">Site 3 operator 6 operator 7</td><td>1.23</td><td>0.02</td><td>1.8</td></tr><tr><td>1.24</td><td>0.02</td><td>1.9</td></tr></table>

<table><tr><td>Hct</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1 operator 2</td><td>40 40</td><td>0.6 0.5</td><td>1.4</td></tr><tr><td>Site 2 operator 3</td><td>39</td><td>0.6</td><td>1.3 1.6</td></tr><tr><td>operator 4 operator 5</td><td>41 40</td><td>0.5 0.6</td><td>1.2 1.4</td></tr></table>

<table><tr><td>pH</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1 operator 2 Site 2 operator 3 operator 4</td><td>7.365 7.368 7.322</td><td>0.006 0.005 0.005</td><td>0.08 0.07 0.07</td></tr><tr><td>operator 5 Site 3 operator 6 operator 7</td><td>7.335 7.303 7.266 7.381</td><td>0.006 0.009 0.006 0.004</td><td>0.08 0.12 0.08 0.05</td></tr><tr><td>pCO2</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1 operator 2 operator 3</td><td>52.3 49.9</td><td>2.0 0.9</td><td>3.8 1.9</td></tr><tr><td>Site 2</td><td>56.9</td><td>0.9</td><td>1.5</td></tr><tr><td>operator 4</td><td>55.4</td><td>1.4</td><td>2.5</td></tr><tr><td>operator 5</td><td>58.9</td><td>1.1</td><td>1.9</td></tr><tr><td>Site 3 operator 6</td><td></td><td></td><td></td></tr><tr><td>operator 7</td><td>61.7 41.5</td><td>1.8 0.9</td><td>2.9 2.1</td></tr></table>

<table><tr><td>pO2</td><td>mean</td><td>SD</td><td>% CV</td></tr><tr><td>Site 1 operator 1</td><td>28.6</td><td>1.7</td><td>6.0</td></tr><tr><td>operator 2</td><td>32.9</td><td>1.8</td><td>5.5</td></tr><tr><td>Site 2 operator 3</td><td>33.9</td><td>1.2</td><td>3.5</td></tr><tr><td>operator 4</td><td>30.0</td><td>1.5</td><td>5.0</td></tr><tr><td>operator 5</td><td>40.1</td><td>1.2</td><td>3.1</td></tr><tr><td>Site 3 operator 6</td><td>61.8</td><td>3.5</td><td>5.6</td></tr><tr><td>operator 7</td><td>74.6</td><td>2.9</td><td>3.9</td></tr></table>

# 5.6.2 Linearity/Reportable Range

This study was performed in-house to demonstrate linearity on whole blood versus an in-house standard method with traceability to NIST standards.

Figure 5.4 - Table - In House Whole Blood Linearity   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Test range</td><td rowspan=1 colspan=1>Units</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>R^{2}$</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>6.4-7.9</td><td rowspan=1 colspan=1>pH units</td><td rowspan=1 colspan=1>1.021</td><td rowspan=1 colspan=1>-0.15</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>10-230</td><td rowspan=1 colspan=1>mm Hg</td><td rowspan=1 colspan=1>1.058</td><td rowspan=1 colspan=1>-3.6</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>pO2</td><td rowspan=1 colspan=1>10-750</td><td rowspan=1 colspan=1>mm Hg</td><td rowspan=1 colspan=1>1.022</td><td rowspan=1 colspan=1>-3.9</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>1.5-12</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>1.006</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>80-190</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>0.973</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>iCa</td><td rowspan=1 colspan=1>0.6-3.7</td><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>1.017</td><td rowspan=1 colspan=1>-0.01</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>Hct</td><td rowspan=1 colspan=1>0-75</td><td rowspan=1 colspan=1>% PCV</td><td rowspan=1 colspan=1>1.005</td><td rowspan=1 colspan=1>-0.58</td><td rowspan=1 colspan=1>0.999</td></tr></table>

# 5.6.3 Traceability

The EPOC System is calibrated is against methods traceable to NIST standards.

The EPOc System's test card comprises an on-board calibration material, prepared gravimetrically and assayed on reference systems calibrated with traceability to NIST standards.

Calibration verification uses commercially available calibration verification fluids whose concentration values are traceable to NIST standards.

Quality control materials are commercially available fluids with concentrations traceable to NIST standards.

# 5.6.4 Detection Limit

Detection limits for the EPOC measurements are those determined by the limits of the reportable range.

# 5.6.5 Analytical Specificity

The following tables summarize data from interference studies performed on the EPOC device. The data are presented as interference bias (test result minus control) expressed as a fraction of TE, the total allowable error (or as a $\%$ bias where indicated).

Figure 5.5 - Table Of Interference Test Data Expressed As Fraction Of Total Allowable Error (TE); Exogenous Interferences   

<table><tr><td rowspan=1 colspan=1>ExogenousInterference</td><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=7>Mean(Test result - blank control)/TE</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>pO2</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>iCa</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>447 mg/dL</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.3</td></tr><tr><td rowspan=1 colspan=1>Sodium pentothal</td><td rowspan=1 colspan=1>1 mmol/L</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>+0.1</td></tr><tr><td rowspan=1 colspan=1>Acetyl salicylate</td><td rowspan=1 colspan=1>4.3 mmol/L</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>+0.2</td></tr><tr><td rowspan=1 colspan=1>Ascorbate</td><td rowspan=1 colspan=1>0.4 mmol/L</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td></tr><tr><td rowspan=1 colspan=1>Salycilate</td><td rowspan=1 colspan=1>4.3 mmol/L</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>-0.1</td></tr><tr><td rowspan=1 colspan=1>Bromide</td><td rowspan=1 colspan=1>18 mmol/L</td><td rowspan=1 colspan=1>-0.6</td><td rowspan=1 colspan=1>+7%</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>-0.3</td></tr><tr><td rowspan=1 colspan=1>Bromide</td><td rowspan=1 colspan=1>37.5 mmol/L</td><td rowspan=1 colspan=1>-1.2</td><td rowspan=1 colspan=1>+13%</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>+0.6</td><td rowspan=1 colspan=1>+0.9</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Iodide</td><td rowspan=1 colspan=1>1 mmol/L</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>5%</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>-0.1</td></tr><tr><td rowspan=1 colspan=1>Iodide</td><td rowspan=1 colspan=1>3 mmol/L</td><td rowspan=1 colspan=1>-1.2</td><td rowspan=1 colspan=1>11%</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>2.2 mmol/L</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.1</td></tr><tr><td rowspan=1 colspan=1>Tylenol</td><td rowspan=1 colspan=1>1.66 mmol/L</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Ammonium</td><td rowspan=1 colspan=1>2 mmol/L</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Lithium</td><td rowspan=1 colspan=1>4 mmol/L</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.1</td></tr><tr><td rowspan=1 colspan=1>Halothane</td><td rowspan=1 colspan=1>2.7%</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td></tr></table>

Figure 5.6 - Table Of Interference Test Data Expressed As Fraction Of Total Allowable Error (TE); Endogenous Interferences   

<table><tr><td rowspan=1 colspan=1>Endogenousinterference</td><td rowspan=1 colspan=1>Level</td><td rowspan=1 colspan=7>Mean(Test result - blank control)/TE</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>pO2</td><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>iCa</td><td rowspan=1 colspan=1>Hct</td></tr><tr><td rowspan=1 colspan=1>NaCl</td><td rowspan=1 colspan=1>20 mmol/L</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>KCI</td><td rowspan=1 colspan=1>8 mmol/L</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.4</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>CaCl</td><td rowspan=1 colspan=1>3 mmol/L</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.4</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>pHpCO2</td><td rowspan=1 colspan=1>+/-0.4 pH-/+60 mm Hg</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-/+0.3</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Bicarbonate</td><td rowspan=1 colspan=1>20 mmol/L</td><td rowspan=1 colspan=1>+0.5</td><td rowspan=1 colspan=1>+0.3</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Lactate</td><td rowspan=1 colspan=1>10 mmol/L</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Hct</td><td rowspan=1 colspan=1>+20% PCV</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>X</td></tr><tr><td rowspan=1 colspan=1>Total Protein</td><td rowspan=1 colspan=1>+3 g/dL</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>+0.8</td></tr><tr><td rowspan=1 colspan=1>Lipids</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.0</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>+0.1</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>9.1 mmol/L</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.3</td></tr><tr><td rowspan=1 colspan=1>Hydroxy butyrate</td><td rowspan=1 colspan=1>20 mmol/L</td><td rowspan=1 colspan=1>+0.4</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.7</td><td rowspan=1 colspan=1>-0.6</td><td rowspan=1 colspan=1>-0.7</td></tr><tr><td rowspan=1 colspan=1>Cysteine</td><td rowspan=1 colspan=1>1 mmol/L</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>0.26 mmol/L</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>+0.2</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>+0.1</td><td rowspan=1 colspan=1>-0.2</td><td rowspan=1 colspan=1>+0.1</td></tr><tr><td rowspan=1 colspan=1>NH4</td><td rowspan=1 colspan=1>2 mmol/L</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>+0.5</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>-0.1</td></tr><tr><td rowspan=1 colspan=1>Phosphate</td><td rowspan=1 colspan=1>2 mmol/L</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>X</td><td rowspan=1 colspan=1>-0.1</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>-0.5</td><td rowspan=1 colspan=1>-0.3</td></tr></table>

# 5.7 Summary of Clinical Tests Submitted in Support of Substantial Equivalence

# 5.7.1 Method comparison with predicate device

The method comparison studies were performed in a field trial at a hospital on patient sample of whole blood at the point of care in the intensive care unit, the cardiac intensive care unit, the hematology/oncology department and in the central lab. Patient specimens were arterial, venous and mixed venous/arterial. The method comparison was against the predicate device.

Figure 5.7 - Table - Method Comparison Summary   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Syx</td><td rowspan=1 colspan=1>R</td><td rowspan=1 colspan=1>X min</td><td rowspan=1 colspan=1>X max</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>149</td><td rowspan=1 colspan=1>0.966</td><td rowspan=1 colspan=1>0.251</td><td rowspan=1 colspan=1>0.02</td><td rowspan=1 colspan=1>0.991</td><td rowspan=1 colspan=1>6.770</td><td rowspan=1 colspan=1>7.982</td></tr><tr><td rowspan=1 colspan=1>pCO2</td><td rowspan=1 colspan=1>143</td><td rowspan=1 colspan=1>1.041</td><td rowspan=1 colspan=1>-0.9</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>0.990</td><td rowspan=1 colspan=1>19.7</td><td rowspan=1 colspan=1>112.2</td></tr><tr><td rowspan=1 colspan=1>pO2</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>1.053</td><td rowspan=1 colspan=1>-1.7</td><td rowspan=1 colspan=1>6.6</td><td rowspan=1 colspan=1>0.978</td><td rowspan=1 colspan=1>26.0</td><td rowspan=1 colspan=1>226.5</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>146</td><td rowspan=1 colspan=1>1.013</td><td rowspan=1 colspan=1>-0.02</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.993</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>7.8</td></tr><tr><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>156</td><td rowspan=1 colspan=1>1.077</td><td rowspan=1 colspan=1>-9.6</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>0.953</td><td rowspan=1 colspan=1>123</td><td rowspan=1 colspan=1>179</td></tr><tr><td rowspan=1 colspan=1>iCa</td><td rowspan=1 colspan=1>156</td><td rowspan=1 colspan=1>1.021</td><td rowspan=1 colspan=1>-0.03</td><td rowspan=1 colspan=1>0.031</td><td rowspan=1 colspan=1>0.985</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>2.2</td></tr><tr><td rowspan=1 colspan=1>Hct</td><td rowspan=1 colspan=1>142</td><td rowspan=1 colspan=1>1.066</td><td rowspan=1 colspan=1>-1.1</td><td rowspan=1 colspan=1>1.36</td><td rowspan=1 colspan=1>0.987</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>73</td></tr></table>

# 5.8 Summary of Conclusions Drawn from Non Clinical and Clinical Tests

We conclude from the data presented in section 5.6 that the device performs effectively. We conclude from the data section 5.7 that the clinical performance of the device is equivalent to the predicate device: i-Stat Model 300 Portable Clinical Analyzer.

# SEP 2 7 2006

Mr. Roy Layer   
Director of Quality Assurance and Regulatory Affairs Epocal, Inc.   
2935 Conroy Road   
Ottawa, Canada K1G 6C6

Re: k061597 Trad/Deviee Name: EPOCTM Blood Analysis System Regulation Number: 21 CFR 862.1120 Regulation Name: Blood gases $( { \mathfrak { p C O } } _ { 2 } , { \mathfrak { p O } } _ { 2 } )$ and blood $\mathsf { p H }$ test system Regulatory Class: Class II Product Code: CHL, CEM, JFP, JPI, JGS Dated: August 19, 2006 Received: August 22 , 2006

Dear Mr. Layer:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either classII (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter willallow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entited;,"Misbranding-by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, Intemational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Interet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/2c8d49e99632bca974b37ace37cfb88bed3f0786b2f9aa548a9c6af86221265c.jpg)

Alberto Gutierrez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indications for Use

510(k) Number (if known): K061597

Device Name: EPOC™ Blood Analysis System

Indications For Use:

The EPOC Blood Analysis System is intended for use by trained medical professionals as an in vitro diagnostic device for the quantitative testing of samples of whole blood in the laboratory or at the point of care in hospitals, nursing homes or other clinical care institutions.

The Blood Gas Electrolyte (BGE) test card panel configuration includes sensors for Sodium - Na, Potassium - K, ionized Calcium - iCa, pH, pCO2, pO2 and Hematocrit - Hct.

Measurement of Sodium and Potassium are used in diagnosis and treatment diseases involving electrolyte imbalance. Measurement of lonized Calcium is used in diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany. Measurement of ph pCO2, p02 (blood gases) is used in the diagnosis and treatment of life-threatening acid-base disturbances. Measurement Hct distinguish normal from abnormal states of blood volume, such as anemia and erythrocytosis.

Page 1 of _1__